首页 工具
登录
购物车

搜索结果

Search Results for " cdk6 "

72

抑制剂 & 化合物

2

天然产物

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T40047 CDK6/9-IN-1

CDK6/9-IN-1

CDK6/9-IN-1 (compound 66) is a potent dual inhibitor of CDK 6 and CDK 9 that can be administered orally. It exhibits inhibitory activity with IC 50 values of 40.5 nM and 39.5 nM against CDK6 and CDK9, respectively.
T18515 Palbociclib-propargyl

PROTAC CDK6 ligand 1

Others Others
Palbociclib-propargyl, a PROTAC ligand targeting the protein CDK6, connects to the CRBN ligand through a PEG linker to form PROTAC CP-10. CP-10 exhibits a potent DC50 value of 2.1 nM against CDK6[1].
T63071 CDK6/PIM1-IN-1

CDK6/PIM1-IN-1 是一种平衡的、有效的、双重 CDK6 (IC50: 39 nM) 和 PIM1 (IC50: 88 nM) 抑制剂。CDK6/PIM1-IN-1 对 CDK4 表现出抑制作用,其 IC50 值为 3.6 nM。CDK6/PIM1-IN-1 能够明显抑制急性髓系白血病 (AML) 细胞增殖,将细胞周期阻滞在 G1 期并诱导细胞凋亡。CDK6/PIM1-IN-1 表现出抗 AML 活性。
T36694 XY028-140

XY028-140

CDK; Ligand for E3 Ligase Cell Cycle/Checkpoint; PROTAC
XY028-140 是一种特异性 CDK4/CDK6 降解,抑制 CDK4/6 在癌细胞中的表达和活性。 XY028-140 是一种 PROTAC,由 Cereblon 配体和 CDK 配体相连接。
T8762 SW106065

SW-106065

Apoptosis Apoptosis
SW106065 是一种恶性外周神经鞘瘤(MPNST)细胞凋亡诱导剂。 它抑制 sMPNST 和其他 MPNST 模型的 ATP 消耗,EC50 为 1 µM。
T6920 ON123300

FGFR; c-RET; JAK; CDK; PDGFR; Src; AMPK Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors
ON123300 是一种可透过血脑屏障的多激酶抑制剂,作用于 CDK4、CDK6、Ark5、PDGFRβ、FGFR1、RET 和 Fyn,IC50值为3.9、9.82、5、26、26、9.2和11 nM。它在脑肿瘤中抑制 Akt 磷酸化及激活 Erk。
T39957 CDK4/6-IN-6

CDK Cell Cycle/Checkpoint
CDK4/6-IN-6CDK4/CDK6的有效抑制剂,结合CDK4/Cyclin D1 和 CDK6/Cyclin D3 的 Ki 为 0.6 nM 和 13.9 nM。
T13202 Trilaciclib hydrochloride

G1T28 hydrochloride

CDK Cell Cycle/Checkpoint
Trilaciclib hydrochloride (G1T28 hydrochloride) 是一种CDK4/6的抑制剂,对 CDK4 和 CDK6 的IC50值分别为 1 nM 和 4 nM。
T10736 CDK4/6-IN-2

CDK Cell Cycle/Checkpoint
CDK4/6-IN-2 是一种CDK4和CDK6抑制剂,IC50分别为 2.7 和 16 nM。
T3111 Abemaciclib methanesulfonate

abemaciclib mesylate,LY2835219,LY2835219 mesylate,LY2835219 (methanesulfonate)

CDK Cell Cycle/Checkpoint
Abemaciclib methanesulfonate (LY2835219) 是一种选择性的CDK4/6抑制剂,能够抑制 CDK4/CDK6 的活性,IC50分别为 2 nM 和 10 nM。
T10220 Abemaciclib metabolite M2

Abemaciclib Metabolites M2

CDK Cell Cycle/Checkpoint
Abemaciclib Metabolites M2 is a metabolite of abemaciclib, acts as a potent CDK4 and CDK6 inhibitor (IC50s: 1-3 nM) with anti-cancer activity.
T11345L Lerociclib dihydrochloride

G1T38 dihydrochloride

CDK Cell Cycle/Checkpoint
Lerociclib dihydrochloride (G1T38 dihydrochloride) 是一种有效的选择性CDK4/CDK6抑制剂,抑制CDK6/CyclinD3和CDK4/CyclinD1,IC50值分别为 2 nM 和 1 nM。
T15335 FN-1501

FLT; CDK Angiogenesis; Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors
FN-1501 是一种有效的 FLT3 和 CDK 抑制剂,具有抗肿瘤的活性,对 CDK2/cyclin A、CDK4/cyclin D1、CDK6/cyclin D1 和 FLT3 的 IC50值分别为 2.47、0.85、1.96 和 0.28 nM。
T8463 PF-06873600

CDK Cell Cycle/Checkpoint
PF-06873600 是一种选择性和口服生物可利用的细胞周期蛋白依赖性激酶 (CDK) 抑制剂(CDK2、CDK4 和 CDK6,Ki 分别为 0.09 nM、0.13 nM 和 0.16 nM),具有潜在的抗肿瘤活性。
T74710 YX-2-107

CDK Cell Cycle/Checkpoint
YX-2-107 是一种具有选择性和高效性的降解 CDK6 的 PROTAC ,IC50 值为 4.4 nM。YX-2-107 在体外对 RB 磷酸化和 FOXM1 表达有抑制作用,对大鼠体内 Ph+ ALL 的发展有抑制作用。YX-2-107 可用于预防和治疗 Ph 染色体阳性 (Ph+) 急性淋巴细胞白血病 (ALL)。
T1785 Palbociclib

PD 0332991,帕博西尼,帕布昔利布

CDK Cell Cycle/Checkpoint
Palbociclib (PD 0332991) 是一种 CDK 抑制剂,抑制 CDK4 和 CDK6 (IC50=11/16 nM),具有口服活性。Palbociclib 具有抗肿瘤活性,有用于 ER 阳性和 HER2 阴性乳腺癌的研究潜力。
T5395 BSJ-03-123

CDK Cell Cycle/Checkpoint
BSJ-03-123是一种有效的 CDK6 选择性小分子降解剂,是由 Cereblon 配体和 CDK 配体相连的 PROTAC。
T6837 Flavopiridol

L868275,Alvocidib,夫拉平度,NSC 649890 HCl,HMR-1275

Apoptosis; HIV Protease; CDK; Autophagy Apoptosis; Autophagy; Cell Cycle/Checkpoint; Microbiology/Virology; Proteases/Proteasome
Flavopiridol (Alvocidib) 是一种广谱CDK 竞争型抑制剂, 抑制 CDK1,CDK2,CDK4的IC50分别为30,170,100 nM。
T10745 CDK9-IN-7

CDK Cell Cycle/Checkpoint
CDK9-IN-7 (compound 21e) 是一种高效选择性的,具有口服活性的 CDK9/cyclin T 抑制剂 (IC50=11 nM),与抑制其他 CDK 相比更有效 (CDK4/cyclinD=148 nM; CDK6/cyclinD=145 nM)。CDK9-IN-7 具有抗癌活性并没有明显的毒性。CDK9-IN-7 诱导非小细胞肺癌 (NSCLC) 细胞凋亡,在 G2 期阻滞细胞周期,并具有抑制非小细胞肺癌干细胞特性。
T6049 SNS-032

SNS032,BMS-387032

Apoptosis; GSK-3; CDK Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells
SNS-032 (BMS-387032) 是选择性的CDK2/7/9有效抑制剂,IC50值分别为 48 nM/62 nM/4 nM。它有抗肿瘤作用。
T21720 GP-82996

Cdk4/6 Inhibitor IV,CINK4

CDK Cell Cycle/Checkpoint
GP-82996 (CINK4) (CINK4) 是 CDK4/6的药理学抑制剂。GP-82996CDK4/cyclin D1、CDK6/cyclin D1 和 Cdk5/p35 的 IC50s 分别为 1.5、5.6 和 25 μM。GP-82996 诱导肿瘤细胞 U2OS 的凋亡,可用于癌症研究。
T1778 AT7519 Hydrochloride

AT7519 HCl,AT 7519 hydrochloride salt

Apoptosis; GSK-3; CDK Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells
AT7519 Hydrochloride (AT7519 HCl) 是一种多CDK 抑制剂,对 CDK1、CDK2、CDK4-CDK6 以及 CDK9 的IC50值分别为 210、47、100、13、170 和 <10 nM。
T6205 AT7519

Apoptosis; GSK-3; CDK Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells
AT7519 是一种CDK 抑制剂,对 CDK1,CDK2,CDK4-CDK6 以及 CDK9 的IC50值分别为 210,47,100,13,170 和 <10 nM。
T2506 AZD-5438

AZD5438

CDK Cell Cycle/Checkpoint
AZD-5438 有效抑制 CDK1,CDK2,CDK9,IC50值分别为 16 nM, 6 nM, 20 nM,但它对 GSK3β,CDK5,CDK6 的抑制作用较弱。
T2378 RGB-286638 free base

GSK-3; MEK; JAK; CDK Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; PI3K/Akt/mTOR signaling; Stem Cells
RGB-286638 free base 是一种新型 CDK 抑制剂,抑制cyclin T1-CDK9、cyclin B1-CDK1、cyclin E-CDK2、cyclin D1-CDK4、cyclin E-CDK3和p35-CDK5活性,IC50分别为 1、2、3、4、5 和 5 nM。它也抑制 GSK-3β、TAK1、Jak2 和 MEK1,IC50值分别为 3、5、50和 54 nM。
T6239 Palbociclib monohydrochloride

PD 0332991 hydrochloride,Palbociclib hydrochloride,帕布昔利布盐酸盐,Palbociclib (PD-0332991) HCl

CDK Cell Cycle/Checkpoint
Palbociclib monohydrochloride (PD 0332991 hydrochloride) 是一种口服的细胞周期蛋白依赖性激酶 (CDK) 抑制剂,具有潜在的抗肿瘤活性。它抑制 CDK4和 CDK6,IC50分别为11 nM,16 nM。它有用于 ER 阳性和 HER2 阴性乳腺癌的研究潜力。
T13627 CP-10

CDK Cell Cycle/Checkpoint
CP-10 is a PROTAC with highly selective and remarkable CDK6 degradation (DC50: 2.1 nM). It inhibits the proliferation of several hematopoietic cancer cells including multiple myeloma and can degrade mutated and overexpressed CDK6.
T13202L Trilaciclib

G1T28

CDK Cell Cycle/Checkpoint
Trilaciclib is an inhibitor of CDK4/6 (IC50s: 1 nM and 4 nM for CDK4 and CDK6, respectively).
T10735 CDK4/6/1 Inhibitor

Crozbaciclib

CDK Cell Cycle/Checkpoint
CDK4/6/1 Inhibitor (Crozbaciclib) 是一种 CDK4/6 抑制剂 (IC50s: 3 and 1 nM). CDK4/6抑制剂是一类用于治疗一些类型的激素受体阳性、her2阴性乳腺癌的化合物,可阻断了乳腺癌细胞分裂和繁殖的过程。
T10737 CDK4/6-IN-3

CDK Cell Cycle/Checkpoint
CDK4/6-IN-3 is a brain-penetrant CDK4/CDK6 inhibitor (Kis: <0.3 nM and 2.2 nM) used for the treatment of glioblastoma. It inhibits CDK1 with a Ki of 110 nM.
T11345 Lerociclib

G1T38

CDK Cell Cycle/Checkpoint
Lerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of 2nM, 1 nM for CDK6/CyclinD3 and CDK4/CyclinD1, respectively.
T22590 AT7519 TFA

AT7519 trifluoroacetate

Others Others
AT7519 is a kinase inhibitor (IC50: 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 μM for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35).
T39956 CDK4/6-IN-5

CDK4/6-IN-5

CDK4/6-IN-5 is a highly effective inhibitor of CDK4 and CDK6, with Ki values of 0.2 and 4.4 nM for CDK4/Cyclin D1 and CDK6/Cyclin D3, respectively (WO2019207463A1, example A93).
T9636 Dalpiciclib

SHR-6390

CDK Cell Cycle/Checkpoint
Dalpiciclib (SHR-6390) 是一种高选择性、口服生物利用度和相当效力的 CDK4 和 CKD6 抑制剂,IC50 分别为 12.4 nM 和 9.9 nM。它通过抑制磷酸化 Rb 蛋白和诱导 G1 细胞周期阻滞在食管鳞状细胞癌中发挥有效的抗肿瘤活性。
T35477 BSJ-Bump

Negative control for BSJ-03-123 . Displays binding and no degradation of Cdk6 in vitro. Brand et al (2019) Homolog-selective degradation as a strategy to probe the function of CDK6 in AML. Cell Chem.Biol. 26 300 PMID:30595531
T15732 Ribociclib succinate

LEE011 琥珀酸盐,瑞博西尼琥珀酸盐,LEE011 succinate

CDK Cell Cycle/Checkpoint
Ribociclib succinate (LEE011 succinate) 是一种高度特异性的CDK4/6抑制剂,IC50值分别为 10 nM 和 39 nM。它对细胞周期蛋白 B/CDK1 复合物的效力低 1000 倍。
TP2133 [Ala92]-p16 (84-103)

Peptide derived from the tumor suppressor protein p16; inhibits cyclin-dependent kinase-4 (cdk4)/cyclin D1 (IC50 ~ 1.5 μM) and binds to cdk6.
T72507 Palbociclib orotate

PD 0332991 orotate

CDK Cell Cycle/Checkpoint
Palbociclib (PD 0332991) orotate 是一种口服活性的CDK4和CDK6选择性抑制剂,其IC50值分别为11 nM和16 nM。该化合物对癌细胞展示出抗增殖效果,并促使细胞周期处于阻滞状态。该药物适用于HR阳性、HER2阴性乳腺癌以及肝细胞癌的研究。
T12355 Palbociclib-d8

PD 0332991 D8,Palbociclib D8

CDK Cell Cycle/Checkpoint
Palbociclib D8 is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active inhibitor of CDK4 and CDK6 (IC50s of 11 and 16 nM, respectively).
T2381 Abemaciclib

CDK4/6 dual inhibitor,LY2835219

CDK Cell Cycle/Checkpoint
Abemaciclib (LY2835219) 是一种 CDK4/6 的双重抑制剂 (IC50=2/10 nM),具有选择性和特异性。Abemaciclib 具有抗肿瘤活性,被用于治疗晚期或转移性乳腺癌。
T17904 Pomalidomide-PEG1-C2-N3

E3 ligase Ligand-Linker Conjugates 50,Cereblon Ligand-Linker Conjugates 13

Others Others
Pomalidomide-PEG1-C2-N3 is a compound that has been synthesized as a conjugate of an E3 ligase ligand-linker. This compound incorporates the cereblon ligand based on Pomalidomide and a 1-unit PEG linker, which are commonly used in PROTAC technology. Utilizing Pomalidomide-PEG1-C2-N3, it is possible to design a selective CDK6 PROTAC degrader known as CP-10. CP-10 effectively induces the degradation of CDK6, displaying a DC50 value of 2.1 nM[1].
T61378 Anticancer agent 29

Anticancer agent 29 (Compd E/Z-6f) exhibits potent anticancer activity, as indicated by IC50 values of 0.054 μM, 0.127 μM, 0.129 μM, and 0.396 μM for CDK2, CDK1, CDK4, and CDK6, respectively [1].
T60328 CDK4/6-IN-12

CDK4/6-IN-12 是一种有效的细胞周期蛋白依赖性激酶 4/6 抑制剂。CDK4/6-IN-12 对 CDK4 和 CDK6 具有抑制活性,IC50值分别为 592.3 nM 和 3090 nM。 CDK4/6-IN-12 可用于癌症的研究。
T64244 CDK4/6-IN-10

CDK4/6-IN-10 是一种选择性的、有效的、口服具有活力的 CDK4 (IC50: 22 nM) 和 CDK6 (IC50: 10 nM) 抑制剂,具有抗肿瘤效果。CDK4/6-IN-10 具有潜力进行多发性骨髓瘤 (MM) 的研究。
T78130 N-Methyl Palbociclib

Drug Metabolite Metabolism
N-MethylPalbociclib是一种Palbociclib的杂质。Palbociclib(PD 0332991)是一种口服活性的CDK4和CDK6抑制剂。
T61892 CDK4/6-IN-8

CDK4/6-IN-8 (Compound 7p) 是选择性的CDK4(IC50= 5.01 nM)和CDK6(IC50= 3.97 nM)抑制剂。
T35476 BSJ-04-132

Selective Cdk4 degrader. Degrades Cdk4 in Molt-4 cells, with no effect on Cdk6 levels. Displays cereblon-dependent degradation. Jiang et al (2019) Development of dual and selective degraders of cyclin-dependent kinases 4 and 6. Angew.Chem.Int.Ed.Engl. 58 6321 PMID:30802347
T67780 AM5992

CDK4/6-IN-16

CDK Cell Cycle/Checkpoint
AM5992 (化合物195) 是有效的CDK4和CDK6抑制剂(CDK4,IC50=0.013μM)。AM5992可用于CDK4介导的疾病的研究。
T77923 BSJ-03-204 triTFA

CDK Cell Cycle/Checkpoint
BSJ-03-204 triTFA是一种融合了Cereblon配体和CDK配体的PROTAC,作为基于Palbociclib的、高效的CDK4/6双重降解剂,选择性地对CDK4/D1和CDK6/D1表现出26.9 nM和10.4 nM的IC50值。它不会引发IKZF1/3的降解,展现了潜在的抗癌活性。
T63634 Palbociclib dihydrochloride

Palbociclib (PD 0332991) dihydrochloride 是口服具有活力的、选择性的 CDK4 (IC50: 11 nM) 和 CDK6 (IC50: 16 nM) 抑制剂。Palbociclib dihydrochloride 对癌细胞具有抗增殖活性,并阻滞细胞周期,能够用于 HR 阳性和 HER2 阴性乳腺癌,以及肝细胞癌的相关研究。

化合物

CDK6/9-IN-1
Cat.No: T40047
Synonym: CDK6/9-IN-1
Target:
Palbociclib-propargyl
Cat.No: T18515
Synonym: PROTAC CDK6 ligand 1
Target: Others
CDK6/PIM1-IN-1
Cat.No: T63071
Synonym:
Target:
XY028-140
Cat.No: T36694
Synonym: XY028-140
Target: CDK, Ligand for E3 Ligase
SW106065
Cat.No: T8762
Synonym: SW-106065
Target: Apoptosis
ON123300
Cat.No: T6920
Synonym:
Target: FGFR, c-RET, JAK, CDK, PDGFR, Src, AMPK
CDK4/6-IN-6
Cat.No: T39957
Synonym:
Target: CDK
Trilaciclib hydrochloride
Cat.No: T13202
Synonym: G1T28 hydrochloride
Target: CDK
CDK4/6-IN-2
Cat.No: T10736
Synonym:
Target: CDK
Abemaciclib methanesulfonate
Cat.No: T3111
Synonym: abemaciclib mesylate,LY2835219,LY2835219 mesylate,LY2835219 (methanesulfonate)
Target: CDK
Abemaciclib metabolite M2
Cat.No: T10220
Synonym: Abemaciclib Metabolites M2
Target: CDK
Lerociclib dihydrochloride
Cat.No: T11345L
Synonym: G1T38 dihydrochloride
Target: CDK
FN-1501
Cat.No: T15335
Synonym:
Target: FLT, CDK
PF-06873600
Cat.No: T8463
Synonym:
Target: CDK
YX-2-107
Cat.No: T74710
Synonym:
Target: CDK
Palbociclib
Cat.No: T1785
Synonym: PD 0332991,帕博西尼,帕布昔利布
Target: CDK
BSJ-03-123
Cat.No: T5395
Synonym:
Target: CDK
Flavopiridol
Cat.No: T6837
Synonym: L868275,Alvocidib,夫拉平度,NSC 649890 HCl,HMR-1275
Target: Apoptosis, HIV Protease, CDK, Autophagy
CDK9-IN-7
Cat.No: T10745
Synonym:
Target: CDK
SNS-032
Cat.No: T6049
Synonym: SNS032,BMS-387032
Target: Apoptosis, GSK-3, CDK
GP-82996
Cat.No: T21720
Synonym: Cdk4/6 Inhibitor IV,CINK4
Target: CDK
AT7519 Hydrochloride
Cat.No: T1778
Synonym: AT7519 HCl,AT 7519 hydrochloride salt
Target: Apoptosis, GSK-3, CDK
AT7519
Cat.No: T6205
Synonym:
Target: Apoptosis, GSK-3, CDK
AZD-5438
Cat.No: T2506
Synonym: AZD5438
Target: CDK
RGB-286638 free base
Cat.No: T2378
Synonym:
Target: GSK-3, MEK, JAK, CDK
Palbociclib monohydrochloride
Cat.No: T6239
Synonym: PD 0332991 hydrochloride,Palbociclib hydrochloride,帕布昔利布盐酸盐,Palbociclib (PD-0332991) HCl
Target: CDK
CP-10
Cat.No: T13627
Synonym:
Target: CDK
Trilaciclib
Cat.No: T13202L
Synonym: G1T28
Target: CDK
CDK4/6/1 Inhibitor
Cat.No: T10735
Synonym: Crozbaciclib
Target: CDK
CDK4/6-IN-3
Cat.No: T10737
Synonym:
Target: CDK
Lerociclib
Cat.No: T11345
Synonym: G1T38
Target: CDK
AT7519 TFA
Cat.No: T22590
Synonym: AT7519 trifluoroacetate
Target: Others
CDK4/6-IN-5
Cat.No: T39956
Synonym: CDK4/6-IN-5
Target:
Dalpiciclib
Cat.No: T9636
Synonym: SHR-6390
Target: CDK
BSJ-Bump
Cat.No: T35477
Synonym:
Target:
Ribociclib succinate
Cat.No: T15732
Synonym: LEE011 琥珀酸盐,瑞博西尼琥珀酸盐,LEE011 succinate
Target: CDK
[Ala92]-p16 (84-103)
Cat.No: TP2133
Synonym:
Target:
Palbociclib orotate
Cat.No: T72507
Synonym: PD 0332991 orotate
Target: CDK
Palbociclib-d8
Cat.No: T12355
Synonym: PD 0332991 D8,Palbociclib D8
Target: CDK
Abemaciclib
Cat.No: T2381
Synonym: CDK4/6 dual inhibitor,LY2835219
Target: CDK
Pomalidomide-PEG1-C2-N3
Cat.No: T17904
Synonym: E3 ligase Ligand-Linker Conjugates 50,Cereblon Ligand-Linker Conjugates 13
Target: Others
Anticancer agent 29
Cat.No: T61378
Synonym:
Target:
CDK4/6-IN-12
Cat.No: T60328
Synonym:
Target:
CDK4/6-IN-10
Cat.No: T64244
Synonym:
Target:
N-Methyl Palbociclib
Cat.No: T78130
Synonym:
Target: Drug Metabolite
CDK4/6-IN-8
Cat.No: T61892
Synonym:
Target:
BSJ-04-132
Cat.No: T35476
Synonym:
Target:
AM5992
Cat.No: T67780
Synonym: CDK4/6-IN-16
Target: CDK
BSJ-03-204 triTFA
Cat.No: T77923
Synonym:
Target: CDK
Palbociclib dihydrochloride
Cat.No: T63634
Synonym:
Target:
Cat. No. Product Name Target Signaling Pathways
T16324 Nimbolide

Apoptosis; NF-κB; CDK Apoptosis; Cell Cycle/Checkpoint; NF-κB
Nimbolide 是源自印楝叶和花的一种三萜。它抑制CDK4/CDK6激酶活性。它抑制 NF-κB,Wnt,PI3K-Akt,MAPK 和 JAK-STAT 信号通路。它通过抑制NF-κB 而诱导肿瘤细胞凋亡。
T6S0221 Eriocitrin

eriodictyol 7-rutinoside,圣草次甙,Eriodictyol-7-O-Rutinoside,Eriodictioside,圣草次甙;圣草次苷,Eriodictyol glycoside

Apoptosis; Carbonic Anhydrase Apoptosis; Metabolism
Eriocitrin (Eriodictyol-7-O-Rutinoside) 是从柠檬中分离出来的一种黄酮类天然产物,是强效的抗氧化剂。它通过激活线粒体涉及的内在信号传导途径来触发细胞凋亡。它通过上调 p53、cyclin A、cyclin D3 和 CDK6 使 S 期细胞周期停滞,从而抑制肝癌细胞的增殖。

天然产物

Nimbolide
Cat.No: T16324
Synonym:
Target: Apoptosis, NF-κB, CDK
Eriocitrin
Cat.No: T6S0221
Synonym: eriodictyol 7-rutinoside,圣草次甙,Eriodictyol-7-O-Rutinoside,Eriodictioside,圣草次甙;圣草次苷,Eriodictyol glycoside
Target: Apoptosis, Carbonic Anhydrase
共72条,每页50条 1 2
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼